首页>The American Journal of Cardiology>Persistence of I-123-mIBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial)
Persistence of I-123-mIBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial)
作者单位：Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA[1]Virtu Stat Ltd, North Wales, PA USA[2]Vanderbilt Heart & Lung Inst Med Ctr East, Dept Med, Nashville, TN USA[3]Washington DC Vet Affairs Med Ctr, Dept Med, Washington, DC USA[4]Diagram Consulting, Kihei, HI USA[5]
换一批
